Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 29 studies | 36% ± 16% | |
| connective tissue cell | 10 studies | 31% ± 15% | |
| myofibroblast cell | 5 studies | 39% ± 17% | |
| adipocyte | 5 studies | 24% ± 5% | |
| adventitial cell | 4 studies | 31% ± 13% |
Insufficient scRNA-seq data for expression of DPT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 99% | 21258.13 | 453 / 459 | 89% | 23.36 | 990 / 1118 |
| lung | 76% | 3576.60 | 438 / 578 | 73% | 10.66 | 846 / 1155 |
| bladder | 86% | 8799.86 | 18 / 21 | 42% | 6.23 | 210 / 504 |
| thymus | 92% | 6651.85 | 602 / 653 | 35% | 4.80 | 212 / 605 |
| prostate | 70% | 4517.16 | 171 / 245 | 57% | 7.04 | 286 / 502 |
| intestine | 85% | 21777.06 | 825 / 966 | 40% | 4.47 | 213 / 527 |
| uterus | 88% | 8451.59 | 150 / 170 | 34% | 5.83 | 158 / 459 |
| pancreas | 29% | 830.37 | 94 / 328 | 82% | 19.04 | 146 / 178 |
| skin | 53% | 3242.87 | 965 / 1809 | 54% | 7.00 | 253 / 472 |
| stomach | 62% | 7258.18 | 224 / 359 | 42% | 6.59 | 120 / 286 |
| adipose | 99% | 18975.78 | 1189 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 78% | 11603.76 | 1124 / 1445 | 21% | 2.13 | 38 / 183 |
| blood vessel | 91% | 6932.76 | 1210 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 25.67 | 26 / 29 |
| heart | 87% | 9228.88 | 750 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 10.49 | 33 / 45 |
| ovary | 25% | 1989.14 | 45 / 180 | 12% | 1.04 | 53 / 430 |
| liver | 11% | 346.69 | 25 / 226 | 25% | 3.08 | 102 / 406 |
| adrenal gland | 10% | 273.12 | 25 / 258 | 25% | 3.09 | 57 / 230 |
| muscle | 29% | 973.95 | 233 / 803 | 0% | 0 | 0 / 0 |
| kidney | 6% | 288.57 | 5 / 89 | 9% | 1.00 | 83 / 901 |
| brain | 0% | 1.44 | 1 / 2642 | 2% | 0.31 | 11 / 705 |
| spleen | 0% | 11.87 | 1 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 2.01 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_0007155 | Biological process | cell adhesion |
| GO_0005615 | Cellular component | extracellular space |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0005515 | Molecular function | protein binding |
| Gene name | DPT |
| Protein name | Alternative protein DPT Dermatopontin (Tyrosine-rich acidic matrix protein) (TRAMP) |
| Synonyms | |
| Description | FUNCTION: Seems to mediate adhesion by cell surface integrin binding. May serve as a communication link between the dermal fibroblast cell surface and its extracellular matrix environment. Enhances TGFB1 activity. Inhibits cell proliferation. Accelerates collagen fibril formation, and stabilizes collagen fibrils against low-temperature dissociation (By similarity). . |
| Accessions | L8E7N7 ENST00000367817.4 Q07507 |
